As filed with the Securities and Exchange Commission on March 31, 2014

Registration No. 333-169612

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

POST-EFFECTIVE AMENDMENT NO. 1

TO

 

FORM S-8

 

REGISTRATION STATEMENT

Under

The Securities Act of 1933

 


 

XYRATEX LTD

(Exact name of Registrant as specified in its charter)

 


 

Bermuda

 

Not Applicable

(State or other jurisdiction of

 

(I.R.S. Employer

incorporation or organization)

 

Identification Number)

 

Langstone Road
Havant PO9 1SA
United Kingdom

(011) 44 2392 496000

(Address and telephone number, including area code, of registrant’s principal executive offices)

 

XYRATEX LTD

2004 EMPLOYEE STOCK PURCHASE PLAN

(Full title of the plan)

 


 

Brad Driver
46831 Lakeview Blvd.

Fremont, CA 94538

(510) 687-5260

(Name, address, and telephone number, including area code, of agent for service)

 


 

Copy to :

 

Kenneth M. Massaroni

Executive Vice President, General Counsel and

Chief Administrative Officer

Seagate Technology plc

10200 S. De Anza Blvd

P.O. Box 4030

Cupertino, CA 95015

 (408) 658-1000

 


 

 

 



 

DEREGISTRATION OF SECURITIES

 

On September 28, 2010 , the Registrant filed with the Securities and Exchange Commission a registration statement on Form S-8, Registration No. 333-169612 (the “Registration Statement”), for the sale of common shares, par value U.S.$0.01 per share (the “Common Shares”), of the Registrant under the Registrant’s Xyratex Ltd 2004 Employee Stock Purchase Plan, as amended and restated effective as of May 11, 2010.

 

On February 26, 2014, the Registrant’s shareholders approved and adopted, at a special meeting of shareholders, an Agreement and Plan of Merger (the “Agreement”), dated as of December 21, 2013, by and among the Registrant, Seagate Technology International, an exempted limited liability company incorporated and existing under the laws of the Cayman Islands and an indirect subsidiary of Seagate Technology plc (“Parent”), and Phoenix Acquisition Limited, an exempted company incorporated and existing under the laws of Bermuda and a wholly-owned Subsidiary of Parent (“Merger Sub”).  Pursuant to the Agreement, upon the issuance of the Certificate of Merger by the Registrar of Companies in Bermuda on March 31, 2014 (the “Effective Time”), Merger Sub merged with and into the Registrant, and the Registrant continued as the surviving entity of the Merger.

 

As a result of the Merger, the offering pursuant to the Registration Statement has been terminated. In accordance with an undertaking made by the Registrant in the Registration Statement to remove from registration, by means of a post-effective amendment, any Common Shares registered under the Registration Statement which remain unsold at the termination of the offering, the Registrant hereby removes from registration all Common Shares registered under the Registration Statement that remain unsold as of the Effective Time.

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing this Post-Effective Amendment No. 1 to Form S-8 and has duly caused this Post-Effective Amendment No. 1 to Form S-8 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Cupertino, State of California, on this 31 st  day of March, 2014.

 

 

XYRATEX LTD

 

 

 

 

By:

/s/ James Lerner

 

 

Name:

James Lerner

 

 

Title:

Chief Executive Officer

 

Pursuant to the requirements of the Securities Act of 1933, this Post-Effective Amendment No. 1 to Form S-8 has been signed below by the following persons in the capacities and on the dates indicated.

 

Signature

 

Title

 

Date

 

 

 

 

 

/s/ James Lerner

 

Chief Executive Officer

 

March 31, 2014

James Lerner

 

(Principal Executive Officer)

 

 

 

 

 

 

 

/s/ Richard Pearce

 

Chief Financial Officer

 

March 31, 2014

Richard Pearce

 

(Principal Financial and Accounting Officer)

 

 

 

 

 

 

 

By:

/s/ Kenneth M. Massaroni

 

Director

 

March 31, 2014

Kenneth M. Massaroni, duly authorized on behalf of Seagate Technology International

 

 

 

 

 

3


XORTX Therapeutics (NASDAQ:XRTX)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more XORTX Therapeutics Charts.
XORTX Therapeutics (NASDAQ:XRTX)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more XORTX Therapeutics Charts.